SEC Filing Summary: MRI Interventions, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by MRI Interventions, Inc. on June 5, 2012. The report discloses a significant operational milestone regarding the Company's ClearPoint system.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific event rather than a periodic financial statement.
Material Changes and Operational Milestones
- First Clinical Procedure: On June 5, 2012, the Company announced the performance of the first brain biopsy procedure using its ClearPoint system.
- Regulation FD Disclosure: The announcement was made pursuant to Item 7.01 to ensure fair disclosure of material non-public information.
Guidance, Outlook, and Risks
The filing text does not provide specific financial guidance, management commentary on future outlook, or a detailed discussion of risks and contingencies beyond the disclosure of the clinical milestone. The primary focus is the successful execution of the first procedure.
Key Facts for Investor Verification
- Verify the clinical details and patient outcomes of the first brain biopsy performed with the ClearPoint system.
- Confirm the regulatory status of the ClearPoint system following this initial procedure.
- Review the full text of the press release (Exhibit 99.1) for additional context on the procedure's significance.